The present invention relates to piperidine-based renin inhibitor compounds having carboxylate or carboxylic acid terminal groups, and their use in treating cardiovascular events and renal insufficiency.
本发明涉及基于
哌啶的肾素
抑制剂化合物,其具有
羧酸盐或
羧酸末端基团,并且它们在治疗心血管事件和肾功能不全方面的使用。